Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Annals of the Rheumatic Diseases 75.1 (2016): S. 303-310.
- Keyword
-
-
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2016
- Creator
-
Iwamoto, Naoki
Vettori, Serena
Maurer, Britta
Brock, Matthias
Pachera, Elena
Jüngel, Astrid
Calcagni, Maurizio
Gay, Renate E.
Whitfield, Michael L.
Distler, Jörg H. W.
Gay, Steffen
Distler, Oliver
- URN
-
urn:nbn:de:bvb:29-opus4-92928
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Iwamoto, Naoki
- Vettori, Serena
- Maurer, Britta
- Brock, Matthias
- Pachera, Elena
- Jüngel, Astrid
- Calcagni, Maurizio
- Gay, Renate E.
- Whitfield, Michael L.
- Distler, Jörg H. W.
- Gay, Steffen
- Distler, Oliver
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2016
Other Objects (12)
Urokinase-type plasminogen activator receptor in vascular calcification
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Mechanism for cAMP-mediated induction of the urokinase plasminogen activator gene in kidney epithelial cells
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
Soluble urokinase plasminogen activator receptor (suPAR): Its relation to neurological outcome in patients with survived cardiac arrest
The role of urokinase-type plasminogen activator (uPA) in proliferation and signal transduction within breast cancer cells
Urokinase-type plasminogen activator (uPA) als Mediator der durch tissue inhibitor of metalloproteinases-1 (TIMP-1) induzierten Lebermetastasierung
Urokinase-type plasminogen activator receptor in vascular calcification
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Mechanism for cAMP-mediated induction of the urokinase plasminogen activator gene in kidney epithelial cells
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
Soluble urokinase plasminogen activator receptor (suPAR): Its relation to neurological outcome in patients with survived cardiac arrest
The role of urokinase-type plasminogen activator (uPA) in proliferation and signal transduction within breast cancer cells
Urokinase-type plasminogen activator (uPA) als Mediator der durch tissue inhibitor of metalloproteinases-1 (TIMP-1) induzierten Lebermetastasierung
Urokinase-type plasminogen activator receptor in vascular calcification
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Einfluss von Biopsie-, Aufarbeitungs- und Asservierungsbedingungen auf den Nachweis von urokinase type plasminogen activator (uPA) und plasminogen activator inhibitor-1 (PAI-1) beim Mammakarzinom
Mechanism for cAMP-mediated induction of the urokinase plasminogen activator gene in kidney epithelial cells
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
Soluble urokinase plasminogen activator receptor (suPAR): Its relation to neurological outcome in patients with survived cardiac arrest
The role of urokinase-type plasminogen activator (uPA) in proliferation and signal transduction within breast cancer cells